标题/作者	年份
Characteristics of SARS-CoV-2 and COVID-19 B Hu, H Guo, P Zhou, ZL Shi Nature Reviews Microbiology 19 (3), 141-154	2021
Post-acute COVID-19 syndrome A Nalbandian, K Sehgal, A Gupta, MV Madhavan, C McGroder, ... Nature medicine 27 (4), 601-615	2021
SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424	2021
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding TN Starr, AJ Greaney, SK Hilton, D Ellis, KHD Crawford, AS Dingens, ... cell 182 (5), 1295-1310. e20	2020
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ... Science 372 (6544), 815-821	2021
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119	2021
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans KW Ng, N Faulkner, GH Cornish, A Rosa, R Harvey, S Hussain, R Ulferts, ... Science 370 (6522), 1339-1343	2020
SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282	2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16	2021
Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer VA Avanzato, MJ Matson, SN Seifert, R Pryce, BN Williamson, SL Anzick, ... Cell 183 (7), 1901-1912. e9	2020
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion DJ Benton, AG Wrobel, P Xu, C Roustan, SR Martin, PB Rosenthal, ... Nature 588 (7837), 327-330	2020
The T cell immune response against SARS-CoV-2 P Moss Nature immunology 23 (2), 186-193	2022
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299	2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite G Cerutti, Y Guo, T Zhou, J Gorman, M Lee, M Rapp, ER Reddem, J Yu, ... Cell host & microbe 29 (5), 819-833. e7	2021
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13)	2021
Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor P Zhao, JL Praissman, OC Grant, Y Cai, T Xiao, KE Rosenbalm, K Aoki, ... Cell host & microbe 28 (4), 586-601. e6	2020
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein C Toelzer, K Gupta, SKN Yadav, U Borucu, AD Davidson, ... Science 370 (6517), 725-730	2020
Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM C Xu, Y Wang, C Liu, C Zhang, W Han, X Hong, Y Wang, Q Hong, S Wang, ... Science advances 7 (1), eabe5575	2021
Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains T Zhou, Y Tsybovsky, J Gorman, M Rapp, G Cerutti, GY Chuang, ... Cell host & microbe 28 (6), 867-879. e5	2020
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation P Pan, M Shen, Z Yu, W Ge, K Chen, M Tian, F Xiao, Z Wang, J Wang, ... Nature communications 12 (1), 4664	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。